Paroxypropione
Paroxypropione is a synthetic, steroidal antiandrogen that was never marketed. It is a selective antagonist of the androgen receptor (AR) and was studied in the treatment of benign prostatic hyperplasia (BPH) in the 1980s.
Pharmacology[edit | edit source]
Paroxypropione acts as a competitive antagonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). By blocking the actions of androgens, paroxypropione can reduce androgen-dependent symptoms and conditions.
History[edit | edit source]
Paroxypropione was developed in the 1980s as a potential treatment for benign prostatic hyperplasia (BPH), a condition characterized by the enlargement of the prostate due to the influence of androgens. However, it was never marketed.
See also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Admin, Prab R. Tumpati, MD
